IV infusion of casirivimab and imdevimab authorized for treatment of mild-to-moderate COVID-19
New Polio Vaccine Recommendation Issued
The World Health Organization’s (WHO) Prequalification program issued an Emergency Use Listing (EUL) recommendation for the type 2 novel oral polio vaccine (nOPV2).
This announcement on November 13, 2020, will enable the rollout of the nOPV2 vaccine for use in countries affected by circulating vaccine-derived poliovirus type 2 (cVDPV2) outbreaks.
The WHO stated: ‘clinical trials of the new vaccine have shown it to be safe and provide comparable protection against polio, as the currently used type 2 monovalent OPV (mOPV2) vaccine.
Real-time suicide mortality data from police reports in Queensland, Australia, during the COVID-19 pandemic: an interrupted time-series analysis.
Deaths by suicide can increase during infectious disease outbreaks. This study analysed suspected suicide rates in 2020 relative to 2015-19 to assess any early effects of the COVID-19 pandemic in […]
Invasive Pulmonary Aspergillosis in the COVID-19 era: An expected new entity.
Information on the recently COVID-19-associated pulmonary aspergillosis (CAPA) entity is scarce. We describe eight CAPA patients, compare them to colonised ICU patients with coronavirus disease 2019 (COVID-19), and review the […]
Congressional Budget Responses to the Pandemic: Fund Health Care, Not Warfare.
The coronavirus outbreak is not the first crisis to affect a large swath of the nation’s population: the Great Depression, World War II, and the HIV epidemic did so previously. […]
Gender Disaggregation in COVID-19 and Increased Male Susceptibility.
Novel coronavirus disease 2019 (COVID-19) is a growing public health crisis. Despite initial focus on the elderly population with comorbidities, it seems that large studies from the worst affected countries […]
Cutaneous and histopathological features of Coronavirus disease 2019 in pediatrics: A review article.
Prevalence of dermatologic manifestations of COVID-19 disease is estimated between 0.25 % and 3% in children and adolescents. In this review article, we decided to describe cutaneous and histopathological manifestations […]
COVID-19 in pregnancy: A review.
COVID-19 has led on to a global healthcare crisis, similar to none in the recent past. Special emphasis must be laid on the status of pregnant women amid this outbreak, […]
Increased IL-10-producing regulatory T cells are characteristic of severe cases of COVID-19.
The pandemic spread of the coronavirus SARS-CoV-2 is due, in part, to the immunological properties of the host-virus interaction. The clinical presentation varies from individual to individual, with asymptomatic carriers, […]
Distinct expression of SARS-CoV-2 receptor ACE2 correlates with endotypes of chronic rhinosinusitis with nasal polyps.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) entry factors, ACE2 and TMPRSS2, are highly expressed in nasal epithelial cells. However, the association between SARS-CoV-2 and nasal inflammation in chronic rhinosinusitis […]